On Monday, Champions Oncology (NASDAQ:CSBR) discussed fourth-quarter financial results during its ea

Champions Oncology (NASDAQ:CSBR) released third-quarter financial results and hosted an earnings cal

On Thursday, Champions Oncology (NASDAQ:CSBR) discussed first-quarter financial results during its e

Champions Oncology (NASDAQ:CSBR) reported fourth-quarter financial results on Monday. The transcript

Champions Oncology's first-quarter fiscal 2027 results record revenue and margin growth, stronger ad

Champions Oncology, Inc. (CSBR) Q1 2027 Earnings Call Transcript

Champions Oncology NASDAQ: CSBR reported first-quarter fiscal 2027 revenue growth, improved margins

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.05 per share. This is a 400 perce

Oncology services margin improves to 51%; Adjusted EBITDA increases to $671,000 HACKENSACK, NJ / ACC

New molecular imaging capabilities connect longitudinal radiopharmaceutical uptake with biodistribut

Champions Oncology reports fourth-quarter fiscal 2026 growth as revenue gains, margin improvement an

Champions Oncology, Inc. (CSBR) Q4 2026 Earnings Call Transcript

Champions Oncology NASDAQ: CSBR reported record revenue for fiscal 2026 and positive adjusted EBITDA

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analy

Delivers Fourth Consecutive Quarter of Positive Adjusted EBITDA HACKENSACK, NJ / ACCESS Newswire / J

Champions Oncology and Cytek Biosciences have different growth drivers and valuations, but which lif

CSBR and CEPL have levers in place for Gross Margin improvement.

Discover why Zacks rates Champions Oncology as "Neutral", being the first on Wall Street to initiate

HACKENSACK, NJ / ACCESS Newswire / July 20, 2026 / Champions Oncology, Inc. (NASDAQ:CSBR), a global

Champions Oncology, Inc. (NASDAQ: CSBR - Get Free Report) shares passed below its two hundred day mo

Eight studies demonstrate how clinically relevant models and integrated data can reduce translationa

Appointment underscores Champions' focus on leveraging clinically relevant data to power next-genera

Champions Oncology, Inc. (CSBR) Q3 2026 Earnings Call Transcript

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.04 per share which missed the ana

Company remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for t

HACKENSACK, NJ / ACCESS Newswire / March 5, 2026 / Champions Oncology, Inc. (CSBR), a leading transl

Champions Oncology, Inc. (CSBR) Q2 2026 Earnings Call Transcript

Stock News Ford pivots from full EV to hybrids and storage: Ford Motor (F) will discontinue the allâ

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.06 per share which beat the analy

Investors are prepping for this week's earnings reports which include homebuilders, several appa

U.S. stocks fell on Friday, with the S&P 500 dropping over 1% and the Dow gaining 1.1%. The Fear

Stock futures up, focus on HYFT, ARGX, NAVN, AXR, CSBR as they report earnings. Top 2 energy stocks

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.02 per share which beat the analy

Several biotech stocks have seen their strength fade over the past week, with their Momentum scores

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it

Although U.S. stocks closed mixed on Tuesday, there were a few notable insider trades.

Companies Reporting Before The Bell • Cracker Barrel Old (NASDAQ:CBRL) is likely to report quarterl

Companies Reporting Before The Bell • Koninklijke Philips (NYSE:PHG) is projected to report earning

  Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quart

  Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is e

This morning 279 companies reached new 52-week highs.